Insights Hub

What’s New. What’s Coming.

Read the latest quarterly reports and get updates about new drugs on the horizon.

emale pharmacist in white coat checking medication box while using digital tablet in pharmacy
Our Latest Insights

2024 Insights Report

Learn more about the top industry and pharmacy trends driving pharmacy plan spend in 2025 and how our clinical programs can help.
Download Report
Doctor in white coat with stethoscope talking to patient during medical consultation
Insight Report

GLP-1

GLP-1 medications continue to shape pharmacy trends. Learn more about what is behind the growth of GLP-1 medications used to treat diabetes and weight management. 
Download Report
Smiling senior woman with short white hair looking away while standing at homemiling senior woman with short white hair looking away while standing at home
Insight Report

Biosimilars

The biosimilar landscape is quickly evolving with the addition of new therapies, allowing for better access, more choice, and lower costs.
Download Report
Experienced male doctor in white coat with tie looking down against blue background
Insight Report

Cell and Gene Therapy

Cell and gene therapies are transforming the treatment landscape for many diseases, especially for those which have no effective therapies.
Download Report
Pharmacist in white coat using tablet while checking medicine inventory on pharmacy shelves"
Our Latest Pipelines

Q2 2025 Pipeline Report

Learn about new therapies in the pipeline that can enhance treatment options, with a spotlight on the weight management pipeline.
Download Report
Pharmacists in white coats using tablet and clipboard while managing medicine inventory in pharmacy
Pipeline Report

Q1 2025 Pipeline Report

In our Q1 2025 edition, Stelara biosimilars prepare for a Q1 launch, key clinical drugs approach their expected approval dates, and we spotlight the oncology pipeline.
Download Report
Pharmacist in white coat working on computer at modern pharmacy counter
Pipeline Report

Q4 2024 Pipeline Report

In our Q4 2024 edition, FDA tackles Vyvanse® shortages, approves first nasal spray for anaphylaxis, and we spotlight advances in atopic dermatitis treatment.
Download Report

Learn more about how we can improve your pharmacy experience

Request a Consultation

Recent News

Blog

What Were Key 340B Developments in 2025, and What’s Ahead for 2026?

Summary Significant 340B program changes in 2025 were driven by federal and state reforms, with ...
Read More →
Blog

What Changed for PBMs in 2025? 5 Trends and a 2026 Preview

Summary In 2025, PBMs adapted to the rapid growth and changing landscape of GLP-1 therapies ...
Read More →
Blog

Drug Shortages: Q4 Update

Summary Many drug shortages are long-lasting, with the majority carrying over year to year and ...
Read More →
View All Articles
Scroll to Top
vytl logo
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.